Providing advice and guidance on Sales, Marketing, Business Operations and Training to help companies build their talent to grow their business and achieve success in the biotech and pharmaceutical industries. Leverage proven experience, expertise, and the latest industry trends to develop sales strategies, create effective marketing campaigns, streamline business operations, or customize training programs to meet customer needs. Partnering every step of the way.

Designed, built, expanded, and led Commercial sales team successfully establishing Rigel in the Heme / Onc marketplace through the launch of TAVALISSE® (fostamatinib) for cITP. Led 7 front line leaders, 1 Training Director, and up to 60 sales professionals, including creating sales strategy, training programs, and executing marketing campaigns. Managed $89M revenue target tracking to 102% and ~$5M variable spend. Report to Chief Commercial Officer. Led 2023 expansion and hiring of Institutional team, impacting key academic centers for new AML molecule, REZLIDHIA® (olutasidenib). Successfully launched TAVALISSE® (fostamatinib) in June of 2018, achieving 300% to forecast at launch, growing sales of first in class SYK Inhibitor with 6 quarters of significant growth post pandemic. Launched 2nd generation AML (Acute Myeloid Leukemia) targeted therapy for relapsed / refractory mIDH1 patients, tracking to established goal of $13M for rare patient population.

Critical leadership role in establishing and building out KYPROLIS® (carfilzomib) US Sales Force. Managed team of 5 RBDs, 49 Hematology Sales Professionals, and 5 Clinical Oncology Specialists (RNs) covering the eastern US promoting Multiple Myeloma at key academic centers and large community practices. Launch of KYPROLIS® resulted in achieving 7 times established forecast. Reported to SVP of Sales. Established performance expectations for sales results, selling skills, technical knowledge, territory management, promotional activities, IC plan, administrative criteria through collaborative strong teamwork. Increased annual revenues, approaching $1B in sales by 2017. Won 2012 Launch Excellence Award, 2013 and 2015 President's Club by putting patients first, fostering pride in the company, and motivating teams to go the extra mile.

Created structure, hired, provided leadership direction for 12 Regional Account Managers (RAMs) and 2 National Account Managers (NAMs). Partnered to develop initiatives and strategies that positively impacted key oncology practices across the US. Managed $1.5B national revenue target. Reported to Vice President of Market Access. Maximized end of life cycle for TAXOTERE® (docetaxel) through contract generation / design, resulting in >$200M in sales in Q1 2011.

Provided leadership / direction for 7 DMs and 70+ Sales Professionals. Managed $600M regional revenue target. Reported to Vice President of Sales. Turned around inherited region consistently ranked last or near bottom in 2005. Led region to 1st or 2nd national ranking for the next 5 years, through advanced training and enhanced commitment to patients.